| Up
2005P-0013:
CEFIXIME FOR ORAL SUSPENSION, 200 MG/ML, AS AN ABBREVIATED NEW DRUG
APPLICATON (ANDA)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 01/13/2005
|
| 01/13/2005
|
| Drug Industry
|
| Lupin Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Vinita Gupta
|
|
|
|
|
| ACK1
|
| 01/13/2005
|
| 01/13/2005
|
| Federal Government
|
| HFA-305 to Lupin Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
| doc
|
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
|
|
|
| PAV1
|
| 04/11/2005
|
| 04/11/2005
|
| Federal Government
|
| HFD-600 to Lupin Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Gary J. Buehler
|
|
Top | Up
Page last updated
May 11, 2005
kk |
